Europe

  • Boston Scientific obtains CE mark for FARAPOINT

    Boston Scientific Corporation has received CE mark for the FARAPOINTTM Pulsed Field Ablation (PFA) Catheter, the newest PFA catheter in the company’s electrophysiology portfolio. The FARAPOINT PFA Catheter is used for the treatment of right atrial flutter (AFL), delivering ablation to the cavotricuspid isthmus (CTI) area of the heart. The CE mark represents a new [...]

  • Why DSPT compliance is vital to securing healthcare’s mobile frontline

    By Adam Boynton, senior security strategy manager at Jamf Mobile devices have become the NHS’s most quietly transformative tools. Whether on a ward round, at a community visit, or during an emergency response, clinicians now rely on phones and tablets as instinctively as they once reached for a penlight.   These endpoints carry [...]

  • Dr Haus Dermatology expands with two new Dermatologists

    Dr Haus Dermatology is celebrating its 15th anniversary and strengthening its clinical team with the appointment of two new Consultant Dermatologists: Dr Paola De Mozzi and Dr Jason Thomson. Founded in 2010 by internationally recognised dermatologist Dr Ariel Haus, the Harley Street clinic has grown into a trusted destination for evidence-based dermatology, pioneering technologies, and [...]

  • Prostate cancer screening for all UK men not justified – experts

    A national prostate cancer screening programme is not justified for all UK men, the UK National Screening Committee has advised. The committee said mass screening would be "likely to cause more harm than good" and backed testing only for men with BRCA genetic variants. BRCA variants are inherited DNA changes that can raise cancer risk. [...]

  • “We need to move from crisis response to early action” – health tech leaders react to UK Budget

    The UK’s 2025 Autumn Budget has outlined a series of measures with direct implications for the health tech sector, signalling a renewed push to modernise NHS infrastructure and expand tech-enabled care. At the centre of the announcement is £300m in new capital funding for NHS technology, positioned as critical to upgrading digital systems, strengthening data infrastructure [...]

  • Ex-Kaiku founders raise €7.5m for oncology AI system

    Helsinki-based Gosta Labs has raised €7.5m in seed funding to scale its oncology AI operating system for cancer care teams. The company, founded by former Kaiku Health founders Lauri Sippola and Henri Viertolahti, develops technology that automates clinical documentation and transforms patient visits into structured data in real time. Kaiku Health was acquired by Elekta [...]

  • Expert comment: Why wearables won’t win on features alone

    By James Greenfield, CEO, Koto In the late 2000s, we all started seeing wearable technology for the first time. From the trendy Nike FuelBand to the more Dad-adjacent Fitbit, we began counting our steps. Fast forward a few years and suddenly people were talking about sleep scores. Fast forward again and its strain, irregular rhythms [...]

  • Ergéa Group appoints David Rolfe as new Group Chief Executive Officer

    Ergéa, a leading pan-European healthcare company specialising in diagnostic imaging and cancer care, has appointed David Rolfe as Group CEO and named Mark Graves as CEO of Ergéa UK. Effective 24 November 2025, David Rolfe, the outgoing CEO of Ergéa UK, has been appointed CEO of Ergéa Group. As part of this leadership transition, Mark [...]

  • InnotiveDx secures £1m for rapid UTI test development

    Bath-based InnotiveDx has won a £1m grant to advance its rapid UTI test, delivering results in under 60 minutes. The funding from PACE (Pathways to Antimicrobial Clinical Efficacy) will support development of the InnotiveUTI test, which provides bacterial identification and antimicrobial susceptibility testing (checking which antibiotics will work) at the point of care. This tackles [...]

  • NHS-backed fund picks 19 mental health startups

    An NHS-backed mental health fund has picked 19 startups for its second cohort, with each eligible to pitch for up to £1m. The Innovations in Mental Health (IMH) Fund’s 12-week immersion programme will focus on companies developing solutions for depression, anxiety and psychosis-related disorders. The fund also announced its first investment in Affiniti AI, which [...]